These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 26979522)
21. Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytes. Eldridge S; Guo L; Mussio J; Furniss M; Hamre J; Davis M Toxicol Sci; 2014 Oct; 141(2):547-59. PubMed ID: 25055963 [TBL] [Abstract][Full Text] [Related]
22. Neuregulin-1 enhances survival of human astrocytic glioma cells. Ritch PS; Carroll SL; Sontheimer H Glia; 2005 Aug; 51(3):217-28. PubMed ID: 15812817 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function. Li SY; Fang CX; Aberle NS; Ren BH; Ceylan-Isik AF; Ren J J Endocrinol; 2005 Sep; 186(3):491-503. PubMed ID: 16135669 [TBL] [Abstract][Full Text] [Related]
24. Serine 474 phosphorylation is essential for maximal Akt2 kinase activity in adipocytes. Kearney AL; Cooke KC; Norris DM; Zadoorian A; Krycer JR; Fazakerley DJ; Burchfield JG; James DE J Biol Chem; 2019 Nov; 294(45):16729-16739. PubMed ID: 31548312 [TBL] [Abstract][Full Text] [Related]
25. Insulin upregulates the expression of epithelial sodium channel in vitro and in a mouse model of acute lung injury: role of mTORC2/SGK1 pathway. He J; Qi D; Wang DX; Deng W; Ye Y; Feng LH; Zhu T; Zhao Y; Zhang CR Exp Cell Res; 2015 Feb; 331(1):164-175. PubMed ID: 25265063 [TBL] [Abstract][Full Text] [Related]
26. Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition. Han EK; Leverson JD; McGonigal T; Shah OJ; Woods KW; Hunter T; Giranda VL; Luo Y Oncogene; 2007 Aug; 26(38):5655-61. PubMed ID: 17334390 [TBL] [Abstract][Full Text] [Related]
27. Leucine facilitates the insulin-stimulated glucose uptake and insulin signaling in skeletal muscle cells: involving mTORC1 and mTORC2. Liu H; Liu R; Xiong Y; Li X; Wang X; Ma Y; Guo H; Hao L; Yao P; Liu L; Wang D; Yang X Amino Acids; 2014 Aug; 46(8):1971-9. PubMed ID: 24806638 [TBL] [Abstract][Full Text] [Related]
28. Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes. Kuramochi Y; Guo X; Sawyer DB J Mol Cell Cardiol; 2006 Aug; 41(2):228-35. PubMed ID: 16769082 [TBL] [Abstract][Full Text] [Related]
29. The involvement of Akt, mTOR, and S6K in the in vivo effect of IGF-1 on the regulation of rat cardiac Na Banjac K; Obradovic M; Zafirovic S; Essack M; Gluvic Z; Sunderic M; Nedic O; Isenovic ER Mol Biol Rep; 2024 Apr; 51(1):517. PubMed ID: 38622478 [TBL] [Abstract][Full Text] [Related]
30. Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes. Aragón-Herrera A; Feijóo-Bandín S; Rodríguez-Penas D; Roselló-Lletí E; Portolés M; Rivera M; Bigazzi M; Bani D; Gualillo O; González-Juanatey JR; Lago F Endocrine; 2018 Apr; 60(1):103-111. PubMed ID: 29411306 [TBL] [Abstract][Full Text] [Related]
32. mTORC2 phosphorylation of Akt1: a possible mechanism for hydrogen sulfide-induced cardioprotection. Zhou Y; Wang D; Gao X; Lew K; Richards AM; Wang P PLoS One; 2014; 9(6):e99665. PubMed ID: 24949720 [TBL] [Abstract][Full Text] [Related]
33. Selenium deficiency-induced thioredoxin suppression and thioredoxin knock down disbalanced insulin responsiveness in chicken cardiomyocytes through PI3K/Akt pathway inhibition. Yang J; Hamid S; Cai J; Liu Q; Xu S; Zhang Z Cell Signal; 2017 Oct; 38():192-200. PubMed ID: 28734787 [TBL] [Abstract][Full Text] [Related]
34. Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2. Matheny RW; Lynch CM; Leandry LA Growth Factors; 2012 Dec; 30(6):367-84. PubMed ID: 23137199 [TBL] [Abstract][Full Text] [Related]
35. Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72. Ham YM; Mahoney SJ Exp Cell Res; 2013 Jun; 319(10):1451-62. PubMed ID: 23567182 [TBL] [Abstract][Full Text] [Related]
36. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers. Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158 [TBL] [Abstract][Full Text] [Related]
37. α Sato M; Evans BA; Sandström AL; Chia LY; Mukaida S; Thai BS; Nguyen A; Lim L; Tan CYR; Baltos JA; White PJ; May LT; Hutchinson DS; Summers RJ; Bengtsson T Biochem Pharmacol; 2018 Feb; 148():27-40. PubMed ID: 29175420 [TBL] [Abstract][Full Text] [Related]